These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21426030)

  • 21. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Entamoeba histolytica: computer-assisted modeling of phosphofructokinase for the prediction of broad-spectrum antiparasitic agents.
    Byington CL; Dunbrack RL; Whitby FG; Cohen FE; Agabian N
    Exp Parasitol; 1997 Nov; 87(3):194-202. PubMed ID: 9371084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Trichomonas vaginalis activity of chalcone and amino-analogues.
    Trein MR; Rodrigues E Oliveira L; Rigo GV; Garcia MAR; Petro-Silveira B; da Silva Trentin D; Macedo AJ; Regasini LO; Tasca T
    Parasitol Res; 2019 Feb; 118(2):607-615. PubMed ID: 30535524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amoebic liver abscess or is it?
    Hu KC; Lin CC; Wang TE; Liu CY; Chen MJ; Chang WH
    Gut; 2008 May; 57(5):627, 683. PubMed ID: 18408101
    [No Abstract]   [Full Text] [Related]  

  • 25. Neonatal Trichomonas vaginalis infection: a case report and review of literature.
    Trintis J; Epie N; Boss R; Riedel S
    Int J STD AIDS; 2010 Aug; 21(8):606-7. PubMed ID: 20975098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapeutic options for the treatment of human trichomoniasis.
    Küng E; Fürnkranz U; Walochnik J
    Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Energy production in Entamoeba histolytica: new perspectives in rational drug design.
    Saavedra-Lira E; Pérez-Montfort R
    Arch Med Res; 1996; 27(3):257-64. PubMed ID: 8854380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug repositioning for novel antitrichomonas from known antiprotozoan drugs using hierarchical screening.
    Meneses-Marcel A; Marrero-Ponce Y; Ibáñez-Escribano A; Gómez-Barrio A; Escario JA; Barigye SJ; Terán E; García-Jacas CR; Machado-Tugores Y; Nogal-Ruiz JJ; Arán-Redó VJ
    Future Med Chem; 2018 Apr; 10(8):863-878. PubMed ID: 29589477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Education and imaging. Gastrointestinal: Amebic colitis.
    Kao S; Chiu HH; Liu YW
    J Gastroenterol Hepatol; 2009 Jan; 24(1):167. PubMed ID: 19196401
    [No Abstract]   [Full Text] [Related]  

  • 30. "Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba-current level of knowledge and outlook".
    Harder A
    Parasitol Res; 2002 Jun; 88(6):591. PubMed ID: 12152617
    [No Abstract]   [Full Text] [Related]  

  • 31. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
    Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
    J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous amebiasis with a fatal outcome.
    Al-Daraji WI; Husain EA; Robson A
    Am J Dermatopathol; 2008 Aug; 30(4):398-400. PubMed ID: 18645316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amebiasis: human infection with Entamoeba histolytica.
    Kelsall BL; Ravdin JI
    Prog Clin Parasitol; 1994; 4():27-54. PubMed ID: 7948936
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1H-imidazoles.
    Hernández-Núñez E; Tlahuext H; Moo-Puc R; Torres-Gómez H; Reyes-Martínez R; Cedillo-Rivera R; Nava-Zuazo C; Navarrete-Vazquez G
    Eur J Med Chem; 2009 Jul; 44(7):2975-84. PubMed ID: 19208443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of circulating antibody response to Trichomonas vaginalis: clinical and diagnostic implications.
    Ton Nu PA; Rappelli P; Dessì D; Nguyen VQ; Fiori PL
    Sex Transm Infect; 2015 Dec; 91(8):561-3. PubMed ID: 25887282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antiprotozoal activity of 1-(3-chloro-2-hydroxypropyl)-substituted nitroimidazoles.
    Hoffer M; Grunberg E
    J Med Chem; 1974 Sep; 17(9):1019-20. PubMed ID: 4370421
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and antiprotozoal activity of novel 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole derivatives.
    Pérez-Villanueva J; Hernández-Campos A; Yépez-Mulia L; Méndez-Cuesta C; Méndez-Lucio O; Hernández-Luis F; Castillo R
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4221-4. PubMed ID: 23731944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiamebic effect of metronidazole proved in a study conducted in Cienfuegos province].
    Galindo LF; Ferrer Mde L; Valdés LS; Iglesias HM; Goodridge IM; Mesa JL
    Rev Cubana Med Trop; 2002; 54(2):101-5. PubMed ID: 15849935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of macrolides vs. metronidazole against Entamoeba histolytica clinical isolates.
    Georgopoulos A; Linnau KF; Buxbaum A; Coste C; Ramirez de Los Santos MA; Shabpar A; Graninger W
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):593-6. PubMed ID: 11571837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of urogenital trichomoniasis of both sexes with tinidazol (Fasygin)].
    Rainer A
    Wien Med Wochenschr; 1974 Oct; 124(42-43):625-6. PubMed ID: 4548265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.